Heather L. McArthur, Stephanie Rice, Isaac Chan, Jorge Henrique Santos Leal, Laura Spring, Katherine Sanchez, Jin Sun Bitar, Nisha Unni, Samira K. Syed, Reva K. Basho, Alison Katherine Conlin, Sasha Stanton, Kelly Perlewitz, Glenda Maria Delgado-Ramos, Namrata Peswani, Yuan Yuan, DAVID CHAN, Sujata Patil, Adam Brufsky, David B. Page. "Event-free survival from the randomized phase 2 neoHIP trial evaluating neoadjuvant taxane, HER2-targeted therapy, +/- pembrolizumab in early-stage HER2-positive breast cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.623